Related references
Note: Only part of the references are listed.Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Rachael Vaubel et al.
BRAIN PATHOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma
Joanna J. Phillips et al.
BRAIN PATHOLOGY (2019)
RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression
Pascal David Johann et al.
BMC BIOINFORMATICS (2019)
Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma
Junji Hosono et al.
WORLD NEUROSURGERY (2019)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Mitsuaki Shirahata et al.
ACTA NEUROPATHOLOGICA (2018)
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
David Capper et al.
ACTA NEUROPATHOLOGICA (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma
Takuya Furuta et al.
NEUROPATHOLOGY (2018)
Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing
Andreas von Deimling et al.
SEMINARS IN NEUROLOGY (2018)
The genetic landscape of ganglioglioma
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis
Andrey Korshunov et al.
BRAIN PATHOLOGY (2018)
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation
Rachael A. Vaubel et al.
BRAIN PATHOLOGY (2018)
Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
Sanda Alexandrescu et al.
BRAIN PATHOLOGY (2016)
BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma
E. Tabouret et al.
EJSO (2015)
Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up
Cristiane M. Ida et al.
BRAIN PATHOLOGY (2015)
DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma
Ramon Martinez et al.
BMC CANCER (2014)
BRAF-Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 Expression
Christian Koelsche et al.
BRAIN PATHOLOGY (2014)
Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation
Shingo Tanaka et al.
BRAIN TUMOR PATHOLOGY (2014)
Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
Bette Kay Kleinschmidt-DeMasters et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler et al.
ACTA NEUROPATHOLOGICA (2011)
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
Dora Dias-Santagata et al.
PLOS ONE (2011)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret J. Dougherty et al.
NEURO-ONCOLOGY (2010)
Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas
R. G. Weber et al.
ONCOGENE (2007)
Malignant progression in pleomorphic xanthoastrocytoma: Personal experience and review of the literature
Elisabetta Marton et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Malignant transformation of pleomorphic xanthoastrocytoma
T Nakajima et al.
ACTA NEUROCHIRURGICA (2006)
Share Paper
